Skip to main content

Published locations for Pembrolizumab-ipilimumab combo is highly active in advanced melanoma

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Pembrolizumab-ipilimumab combo is highly active in advanced melanoma

User login

  • Reset your password
  • /content/pembrolizumab-ipilimumab-combo-highly-active-advanced-melanoma
  • /edermatologynews/article/110395/melanoma/pembrolizumab-ipilimumab-combo-highly-active-advanced
  • /oncologypractice/article/110395/melanoma/pembrolizumab-ipilimumab-combo-highly-active-advanced
  • /hematology-oncology/article/110395/melanoma/pembrolizumab-ipilimumab-combo-highly-active-advanced
  • /dermatology/article/110395/melanoma/pembrolizumab-ipilimumab-combo-highly-active-advanced-melanoma